Literature DB >> 12771709

Management of lymphoceles after renal transplantation: laparoscopic versus open drainage.

T Florian Fuller1, Sang-Mo Kang, Ryutaro Hirose, Sandy Feng, Peter G Stock, Chris E Freise.   

Abstract

PURPOSE: Laparoscopic surgery has become widely accepted for the treatment of lymphoceles following kidney transplantation. In this single center study we retrospectively reviewed our results of the surgical management of post-transplant lymphoceles, assessing indication and outcome of laparoscopic versus open drainage.
MATERIALS AND METHODS: The records of 60 patients who underwent surgical treatment for a symptomatic lymphocele following kidney transplantation or combined kidney/pancreas transplantation were retrospectively reviewed.
RESULTS: Between 1995 and 2002, 1,836 patients received a kidney transplant at the University of California San Francisco. In 60 patients (3.3%) a symptomatic lymphocele developed and either laparoscopic (20) or open drainage (40) was completed. The conversion rate from laparoscopic to open drainage was 16.5%. The most common indications for open lymphocele drainage were noninfectious wound complications (13 patients) and a high risk of vessel or ureter injury (8) due to proximity of the lymphocele to hilar structures. Additional surgery on the graft was required in 5 patients. Intraoperative blood loss was significantly lower in the laparoscopy group. Median hospital stay was 1 day in the laparoscopy group versus 4 days in the open drainage group. No perioperative complications were observed in either group. After a median followup of 38 months, 2 patients in each treatment group had a symptomatic recurrence.
CONCLUSIONS: Although both surgical approaches are safe and effective, laparoscopic drainage should remain the method of choice for the treatment of post-transplant lymphocele. However, open drainage should be performed in patients with wound complications and in those with a small lymphocele adjacent to vital renal structures.

Entities:  

Mesh:

Year:  2003        PMID: 12771709     DOI: 10.1097/01.ju.0000063800.44792.61

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  [Incarcerated hernia after laparoscopic drainage of a lymphocele].

Authors:  F Friedersdorff; C Roller; D Baumunk; M Giessing; K Miller; S Weikert; T F Fuller
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

Review 2.  [Management of urological complications after renal transplantation].

Authors:  J Putz; S Leike; M P Wirth
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639

3.  Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease.

Authors:  Tanya R Flohr; Hugo Bonatti; Tjasa Hranjec; Doug S Keith; Peter I Lobo; Sean C Kumer; Timothy M Schmitt; Robert G Sawyer; Timothy L Pruett; John P Roberts; Kenneth L Brayman
Journal:  J Surg Res       Date:  2011-11-19       Impact factor: 2.192

Review 4.  [Urological evaluation and follow-up of the kidney transplant patient].

Authors:  T F Fuller; L Liefeldt; D Dragun; M Tüllmann; S A Loening; M Giessing
Journal:  Urologe A       Date:  2006-01       Impact factor: 0.639

5.  Perirenal transplant fluid collections.

Authors:  Howard M Richard
Journal:  Semin Intervent Radiol       Date:  2004-12       Impact factor: 1.513

6.  A case of continuous negative pressure wound therapy for abdominal infected lymphocele after kidney transplantation.

Authors:  Marco Franchin; Matteo Tozzi; Gabriele Soldini; Gabriele Piffaretti
Journal:  Case Rep Transplant       Date:  2014-10-08

7.  Extraperitoneal laparoscopic resection for retroperitoneal lymphatic cysts: initial experience.

Authors:  Yichun Wang; Chen Chen; Chuanjie Zhang; Chao Qin; Ninghong Song
Journal:  BMC Urol       Date:  2017-11-13       Impact factor: 2.264

8.  Predictors of symptomatic lymphocele after kidney transplantation.

Authors:  Maja Joosten; Frank C d'Ancona; Wilbert A van der Meijden; Paul P Poyck
Journal:  Int Urol Nephrol       Date:  2019-09-05       Impact factor: 2.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.